iShares IBoxx $ Invest Grade Corp Bd Fd  

(Public, NYSEARCA:LQD)   Watch this stock  
Find more results for LQD
117.32
+0.21 (0.18%)
Jan 20 - Close
NYSEARCA real-time data - Disclaimer
Currency in USD
Range 116.90 - 117.35
52 week 112.67 - 124.48
Open 117.13
Vol. 703,528.00
Mkt cap 27.51B
P/E 15.32
Div/yield 0.32/3.61
EPS 7.66
Shares 233.20M
Beta 0.09
Inst. own 83%

Key stats and ratios

Q1 (Feb '15) 2015
Net profit margin 141.25% 199.13%
Operating margin 95.81% 95.82%
EBITD margin - 95.82%
Return on average assets 4.37% 6.12%
Return on average equity 4.70% 6.60%
CDP Score - -

Address

45 Fremont Street
San Francisco, 94105
United States - Map
+1-800-4742737 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

iShares iBoxx $ Investment Grade Corporate Bond ETF (the Fund), formerly iShares iBoxx $ Investment Grade Corporate Bond Fund, is an exchange-traded fund (ETF). The Fund seeks to track the investment results of the Markit iBoxx USD Liquid Investment Grade Index (the Index), which is a rules-based index consisting of liquid, the United States dollar-denominated, investment-grade corporate bonds for sale in the United States. The Index may include large-, mid- or small-capitalization companies, and components primarily include consumer services, financial, and oil and gas companies. The components of the Index, and the degree to which these components represent certain industries, may change over time. The Index is a subset of the Markit iBoxx USD Corporate Bond Index. The Fund generally invests at least 90% of its assets in securities of the Index and at least 95% of its assets in investment-grade corporate bonds. The Fund’s investment adviser is BlackRock Fund Advisors.

Officers and directors

Joseph Kippels Portfolio Manager of the Manager
Bio & Compensation  - Reuters
Chris Mosellen Portfolio Manager of the Manager
Bio & Compensation  - Reuters
Lee Sterne Senior Portfolio Manager of the Manager
Age: 50
Bio & Compensation  - Reuters
John Sulski Portfolio Manager of the Manager
Bio & Compensation  - Reuters